CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
Go back to CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01| CalAmp Corp. (NASDAQ: CAMP) | Delayed: 4.48 +0.02 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.46 | 52 Week High | $21.34 | |||
| Open | $4.50 | 52 Week Low | $12.13 | |||
| Day High | $4.54 | P/E | 3.37 | |||
| Day Low | $4.42 | EPS | $1.33 | |||
| Volume | 126,863 | |||||

